Madison Clarke
Yellow fever is a serious disease caused by a virus spread by infected mosquitoes. It is found in certain parts of Africa and South America. The yellow fever vaccine is a highly effective travel vaccine that protects against the disease. It is a live-attenuated vaccine, meaning it contains a weakened form of the virus. The vaccine is recommended for people living in or travelling to areas where there is a risk of yellow fever. So, are Americans vaccinated for yellow fever at birth?
| Characteristics | Values |
|---|---|
| Who should get the yellow fever vaccine? | The vaccine is recommended for people aged 9 months or older who are living in or traveling to parts of Africa or South America where there’s a risk of yellow fever. It’s also recommended for people studying yellow fever in labs. |
| How often should the vaccine be administered? | A single dose of the yellow fever vaccine provides lifetime protection for most people. However, some countries may require proof of vaccination within the last 10 years, and booster shots are recommended for people who remain at risk. |
| Where can the vaccine be administered? | Vaccines are available at the doctor’s office, pharmacies, or approved vaccination centers. |
| Are there any side effects or risks associated with the vaccine? | Side effects are generally mild and may include redness or pain at the injection site, headaches, muscle aches, and low-grade fevers. Severe side effects, although rare, may include serious allergic reactions, organ failure, and neurological problems. The vaccine should not be given to those with weak immune systems or severe allergies. |
| Is a prescription required for the vaccine? | A prescription is typically not required to get a yellow fever vaccine. |
Explore related products
![International Certificate of Vaccination with Vinyl Document Holder - World Health Organization Bilingual Version [cards] World Health Organization [Jan 01, 2007]](https://m.media-amazon.com/images/I/61SHjBP1VYL._AC_UY218_.jpg)
What You'll Learn
- Yellow fever vaccination is recommended for Americans travelling to high-risk areas
- The vaccine is safe for most, but some may experience mild side effects
- It is a live-attenuated vaccine, providing lifelong protection
- The vaccine is not required for those not travelling to high-risk areas
- Some countries require proof of vaccination for entry
Yellow fever vaccination is recommended for Americans travelling to high-risk areas
Yellow fever is a mosquito-borne virus found in parts of Africa and South America. The Haemagogus mosquito, which spreads the disease, is commonly found in Central and South America. The Aedes aegypti mosquito can transmit the disease in both rural and urban areas. The risk of infection is greatest during the rainy season (January to May, with a peak in February and March).
The yellow fever vaccine is a highly effective travel vaccine that contains a weakened form of the virus. It is recommended for people who are travelling to or living in areas where yellow fever is present. The vaccine is given as a single dose and provides lifetime protection for most people. It is recommended for people aged 9 months or older. Those under 9 months or over 60 years may need to consult a healthcare provider before vaccination.
The CDC recommends the yellow fever vaccine for people travelling to areas classified as having endemic or transitional risk of yellow fever transmission. For a two-week stay in West Africa, the estimated risk of illness for an unvaccinated traveller is 50 per 100,000, and the risk of death is 10 per 100,000. The risk is lower in South America, with an estimated risk of illness of 5 per 100,000 and a risk of death of 1 per 100,000.
Some countries require proof of yellow fever vaccination for entry, and this may need to have been administered within the last 10 years. It is important to check the entry requirements for your destination country before travelling.
The Mystery of Hand, Foot and Mouth: Vaccine Elusive
You may want to see also
Explore related products
The vaccine is safe for most, but some may experience mild side effects
The yellow fever vaccine is generally safe and is recommended for people living in or travelling to areas where there is a risk of yellow fever, such as parts of Africa and South America. The vaccine is a live, weakened form of the virus, and a single dose is typically sufficient to provide lifelong protection for most people.
However, it's important to note that some individuals may experience mild side effects after receiving the yellow fever vaccine. These side effects are similar to those associated with other vaccines and usually include redness and mild pain at the injection site, headaches, muscle aches, and low-grade fevers. These side effects are typically mild and temporary, lasting only a few days.
While rare, more severe side effects can occur in some individuals. For example, severe allergic reactions occur in approximately eight out of every million doses, and serious neurological problems occur in about four out of every million doses. Organ failure is an extremely rare but possible complication, with only about three cases per million doses.
It is recommended that individuals consult with a healthcare provider before receiving the yellow fever vaccine to assess their personal risk factors and determine if the benefits outweigh the risks. This is especially important for those who are pregnant, breastfeeding, or have underlying medical conditions, such as a weakened immune system or HIV. Additionally, those under nine months or over 60 years old should consult a healthcare provider before receiving the vaccine, as they may be at a higher risk of experiencing side effects.
Which Vaccines Have I Taken? Check Your Records
You may want to see also
Explore related products
It is a live-attenuated vaccine, providing lifelong protection
Yellow fever is a serious disease caused by a virus transmitted by infected mosquitoes. It is not found in the United States, and vaccination has ensured that travellers rarely contract the disease. However, it is prevalent in parts of Africa and South America, affecting around 180,000 people annually in Africa alone.
The yellow fever vaccine is a live-attenuated vaccine, which means it contains a weakened form of the virus. This form is known as the 17D strain, discovered by Max Theiler, Hugh Smith, and Eugen Haagen in 1937. This strain was found to be highly effective, and it is the only one in use today. The live-attenuated vaccine trains the body to build immunity without causing the disease. The vaccine is safe for most people, including those with asymptomatic HIV, and is even recommended during pregnancy for those at risk of exposure. However, those with weakened immune systems, such as those with HIV/AIDS, should not receive the vaccine. Additionally, those who have had a severe allergic reaction to the vaccine or any of its ingredients, such as eggs, chicken proteins, or gelatin, should avoid it.
The vaccine is recommended for people aged 9 months or older who are living in or travelling to areas where yellow fever is a risk. This includes both travellers to affected regions and residents of these areas. An International Certificate of Vaccination or Prophylaxis (ICVP) is often required for entry into countries where yellow fever is present. A single dose of the vaccine is typically sufficient and provides lifelong protection for most individuals. Booster shots are generally not needed, as immunity does not appear to decrease over time. However, some countries may require proof of recent vaccination, such as within the last 10 years.
Yellow fever vaccination is easily accessible and is typically available at doctors' offices and pharmacies. It is also offered at approved vaccination centres, such as Walgreens, which can provide the necessary certification for travellers. The vaccine is generally safe, with mild and common side effects, including headaches, muscle aches, and low-grade fevers. Severe allergic reactions are rare, occurring in about eight per million doses. Overall, the yellow fever vaccine is highly effective in preventing the disease and is recommended for those at risk of exposure.
Hepatitis A Vaccine: When Was It Introduced?
You may want to see also
Explore related products
The vaccine is not required for those not travelling to high-risk areas
The yellow fever vaccine is not a routine vaccine in the US and is not required for those not travelling to high-risk areas. It is only recommended for people who are planning to travel to, or currently live in, areas where there is an active risk of contracting the disease. This includes parts of Africa and South America.
Yellow fever is a serious disease caused by a virus spread by infected mosquitoes. It is not found in the United States and is primarily found in certain parts of Africa and tropical South America. The virus can cause a range of symptoms, from mild fever and headache to severe liver disease, and in some cases, organ failure or bleeding. In the nineteenth century, African populations were believed to have a "natural immunity" to the illness due to their burial traditions, which included burying the deceased near their habitations. However, this perception was dispelled when these burial traditions were abandoned, and local populations began to die of yellow fever at similar rates to those without such customs.
The yellow fever vaccine is a highly effective travel vaccine that can protect against the disease. It is a live-attenuated vaccine, which means it contains a weakened form of the virus that trains the body to build immunity without causing the disease. The vaccine is safe for most people, including those with HIV infection but without symptoms, and side effects are typically mild. However, those with weakened immune systems or severe allergies should exercise caution and consult a doctor before receiving the vaccine.
The vaccine is typically given as a single shot at least 10 days prior to travel and provides lifetime protection for most individuals. Some countries that are affected by yellow fever require proof of vaccination for entry, such as an International Certificate of Vaccination or Prophylaxis (ICVP). It is important to note that the vaccine is not a substitute for other preventive measures, such as mosquito bite prevention, and travellers should continue to take precautions to avoid mosquito bites during their trip.
Vaccine Eligibility in Washington State: Who Qualifies?
You may want to see also
Explore related products
Some countries require proof of vaccination for entry
Yellow fever is a mosquito-borne virus found in parts of Africa and South America. The yellow fever vaccine is a highly effective travel vaccine that contains a weakened form of the virus. This vaccine is recommended for people aged 9 months or older who are travelling to or living in areas at risk for the yellow fever virus.
While the vaccine provides lifetime protection, some countries still require proof of vaccination within the last 10 years for entry. This is known as the International Certificate of Vaccination or Prophylaxis (ICVP).
- Benin
- Burkina Faso
- Burundi
- Cameroon
- Central African Republic
- Congo
- Côte d’Ivoire
- DRC
- Gabon
- Guinea-Bissau
- Kenya
- Liberia
- Rwanda
- Sierra Leone
- Niger
- Togo
It is important to note that country requirements are subject to change at any time. Therefore, travellers should consult with their healthcare provider and check the latest travel advice before their trip.
The BCG Vaccine: Why Does It Leave a Mark?
You may want to see also
Frequently asked questions
No, Americans are not vaccinated for yellow fever at birth. The yellow fever vaccine is recommended for people aged 9 months and older who are travelling to or living in areas where there is a risk of yellow fever.
The World Health Organization recommends the vaccine for people between the ages of 9 and 12 months in areas where the disease is common.
Side effects of the yellow fever vaccine are generally mild and may include headache, muscle pains, pain at the injection site, fever, and rash.
The yellow fever vaccine is highly effective and provides lifelong protection for most people. Since the 1930s, only 12 known cases of yellow fever have been identified after 600 million doses have been dispensed.
Yellow fever is commonly found in parts of Africa and South America.
